GUTS
Fractyl Health Inc.

1,388
Mkt Cap
$315.2M
Volume
2.06M
52W High
$3.03
52W Low
$0.825
PE Ratio
-1.01
GUTS Fundamentals
Price
$2.36
Prev Close
$2.30
Open
$2.32
50D MA
$1.45
Beta
1.14
Avg. Volume
2.19M
EPS (Annual)
-$1.44
P/B
-95.67
Rev/Employee
$869.16
Loading...
Loading...
News
all
press releases
Fractyl Health (NASDAQ:GUTS) CEO Acquires $19,998.72 in Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) CEO Harith Rajagopalan bought 10,416 shares of the stock in a transaction on Thursday, December 4th. The stock was acquired at an average cost of...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Insider Buying: Fractyl Health (NASDAQ:GUTS) CEO Buys 10,416 Shares of Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) CEO Harith Rajagopalan bought 10,416 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The shares were acquired...
MarketBeat·4d ago
News Placeholder
Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs
Fractyl Health (NASDAQ: GUTS) released positive 6-month results from its REVEAL-1 study in obese patients who discontinued GLP-1 therapy.read more...
Benzinga·10d ago
News Placeholder
Fractyl's Revita Procedure Shows 6-Month Post-GLP-1 Weight Stability In REVEAL-1 Study
(RTTNews) - Fractyl Health (GUTS) reported new six-month data from its open-label REVEAL-1 cohort, showing that people with obesity who stopped GLP-1 drugs maintained both weight and glycemic control...
Nasdaq News: Markets·10d ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) have received an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat...
MarketBeat·19d ago
News Placeholder
Canaccord Genuity Group Issues Positive Forecast for Fractyl Health (NASDAQ:GUTS) Stock Price
Canaccord Genuity Group raised their target price on Fractyl Health from $6.00 to $8.00 and gave the stock a "buy" rating in a research report on Friday...
MarketBeat·20d ago
News Placeholder
Brokers Set Expectations for Fractyl Health FY2025 Earnings
Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) - Analysts at HC Wainwright lifted their FY2025 earnings per share estimates for Fractyl Health in a report issued on Thursday, November 13th. HC...
MarketBeat·25d ago
News Placeholder
Fractyl Health (NASDAQ:GUTS) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Fractyl Health (NASDAQ:GUTS - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.71) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·29d ago
News Placeholder
Preview: Fractyl Health's Earnings
read more...
Benzinga·1mo ago
News Placeholder
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PR Newswire VANCOUVER, Oct. 21, 2025 Equity...
PR Newswire·2mo ago

Latest GUTS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.